(Q34671602)

3 August 2017

1 reference

title

Gold derivatives for the treatment of cancer (English)

1 reference

3 August 2017

1

Edward R T Tiekink

1 reference

3 August 2017

publication date

1 June 2002

1 reference

Critical Reviews in Oncology Hematology

3 August 2017

published in

1 reference

3 August 2017

volume

42

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

225-248

1 reference

The history of gold therapy in rheumatoid disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Gold in medicine: a review of its use in the West before 1900.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Gold in Medicine - Chrysotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

The chemistry of gold drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Gold-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Crystal Structure of the Antiarthritic Drug Gold Thiomalate (Myochrysine): A Double-Helical Geometry in the Solid State

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Structures of gold(i) and silver(i) thiolate complexes of medicinal interest: a review and recent results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Complexes of metals other than platinum as antitumour agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

1 reference

7 January 2021

Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Cancer in rheumatoid arthritis: a prospective long-term study of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Inhibitory effects of a new oral gold compound on hela cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Antitumor effect of gold as revealed by growth suppression of cultured cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Effect of gold on survival of tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Antimicrobial and anticancer activity of tetrahedral, chelated, diphosphine silver(I) complexes: comparison with copper and gold

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

A Novel Anionic Gold-Indium Cluster Compound: Synthesis and Molecular and Electronic Structure

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

In vivo and in vitro cardiotoxicity of a gold-containing antineoplastic drug candidate in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Antitumor activity of gold(i), silver(i) and copper(i) complexes containing chiral tertiary phosphines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Chiral phosphine ligands derived from sugars 10. Syntheses, structure, characterization, and antitumor activity of the gold(I) complexes with sugar-substructure phosphine ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Synthesis and biological activity of gold and tin compounds in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Nitrogen, sulfur and oxygen donor adducts with copper(II) complexes of antitumor 2-formylpyridinethiosemicarbazone analogs: physicochemical and cytotoxic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

The (8-thiotheophyllinate) (triphenylphosphine) gold (1), (tTAUP): a new gold complex as an anticancer agent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Anti-arthritic activity in rats of some phosphinegold(i) thionucleobases and related thiolates

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

In vitro antitumour activity of some triorganophosphinegold(i) thionucleobases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Anti-tumor activity, in vitro and in vivo, of some triphenylphosphinegold(i) thionucleobases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

A Study of the Antitumour Activity of Four Triorganophosphinegold(I) Thiolates: R(3) PAu(SR'), R = Ph, Cy, Et; SR'H = 6-Mercaptopurine and R = Et; SR'H = 6-Thioguanine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Characterisation and in vitro cytotoxicity of triorganophosphinegold(i) 2-mercaptobenzoate complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Synthesis, Structure of Nitrogen-Containing Phosphinogold(I) Ferrocenes. In vitro Activity against Bladder and Colon Carcinoma Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Biological properties of two gold(III) complexes: AuCl3 (Hpm) and AuCl2 (pm)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Gold(III) compounds as potential antitumor agents: Cytotoxicity and DNA binding properties of some selected polyamine-gold(III) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Structure and DNA binding properties of the gold(III) complex [AuCl2(esal)]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Chemical and Biological Studies of Dichloro(2-((dimethylamino)methyl)phenyl)gold(III)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

Biologically-Active Gold(III) Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

A Screening Strategy for Metal Antitumor Agents as Exemplified by Gold(III) Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900216-5

7 January 2021

10.1016/S1040-8428(01)00216-5

Identifiers

DOI

1 reference

3 August 2017

1 reference